When blood pressure drops too much, it can reduce the delivery of oxygen and other nutrients below a critical threshold that causes injury to the nerve fibers
Most patients see noticeable appetite reduction within the first week and measurable weight loss by week three to four
Tesofensine May Be Better For: Patients who strongly prefer oral medication over injections Individuals whose eating patterns are driven primarily by cravings, emotional eating, or reward-seeking behavior (dopamine-mediated eating) Patients who have not responded adequately to GLP-1 medications Those who tolerate stimulant-type medications well Individuals without significant cardiovascular risk factors Semaglutide May Be Better For: Patients with type 2 diabetes or prediabetes (dual benefit of weight loss and glycemic control) Individuals with cardiovascular disease or elevated cardiovascular risk (proven cardioprotective benefit) Patients who prefer weekly dosing over daily medication Those who experience primarily volume-driven overeating rather than craving-driven eating Individuals with a history of anxiety or insomnia (since semaglutide does not have stimulant properties) Combination Therapy Some physicians prescribe tesofensine and semaglutide together, leveraging their complementary mechanisms tesofensine addressing central nervous system-mediated cravings while semaglutide handles peripheral satiety and metabolic improvements
.webp)
And we know thats not happening because we have a lot of literature showing that GLP-1s tend to decrease the risk of death
Weight loss seems to be slightly higher in non-CKD patients and, among those diagnosed with CKD, in those with less severe forms
Los principios activos se depositan en la dermis y se difunden hacia el tejido subcutneo, donde actan sobre los adipocitos (las clulas grasas). El procedimiento combina tres mecanismos que actan de forma conjunta: Administracin directa , cerca de la diana teraputica, lo que aumenta la eficacia del tratamiento
